Article
The Ins and Outs of RAS Effector Complexes.
Biomolecules - 7 Feb 2021
Kiel Christina, Matallanas David, Kolch Walter
Abstract excerpt
RAS oncogenes are among the most commonly mutated proteins in human cancers. They regulate a wide range of effector pathways that control cell proliferation, survival, differentiation, migration and metabolic status. Including aberrations in these pathways, RAS-dependent signaling is altered in more than half of human cancers. Targeting mutant RAS proteins and their downstream oncogenic signaling pathways has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
